CVE-2023-5983

CVE-2023-5983 is a high-severity vulnerability in Botanikyazilim Pharmacy Automation with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-359.

Key facts

Description

Exposure of Private Personal Information to an Unauthorized Actor vulnerability in Botanik Software Pharmacy Automation allows Retrieve Embedded Sensitive Data. This issue affects Pharmacy Automation: before 2.1.133.0.

Frequently asked questions

What is CVE-2023-5983?
Exposure of Private Personal Information to an Unauthorized Actor vulnerability in Botanik Software Pharmacy Automation allows Retrieve Embedded Sensitive Data. This issue affects Pharmacy Automation: before 2.1.133.0.
How severe is CVE-2023-5983?
CVE-2023-5983 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2023-5983 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (46th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-5983?
CVE-2023-5983 affects Botanikyazilim Pharmacy Automation. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-5983?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-5983 published?
CVE-2023-5983 was published on 2023-11-22 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-359 vulnerabilities

Browse all CWE-359 vulnerabilities →